{"id":2972,"date":"2019-04-09T01:48:00","date_gmt":"2019-04-09T06:48:00","guid":{"rendered":"https:\/\/worldcarenew.wpenginepowered.com\/?p=2972"},"modified":"2026-03-08T02:24:12","modified_gmt":"2026-03-08T07:24:12","slug":"poskytovatelia-mso-z-konzorcia-worldcare-dana-farber-a-detska-nemocnica-v-bostone-vyvijaju-preventivne-opatrenie-proti-rakovine-prsnika","status":"publish","type":"post","link":"https:\/\/www.worldcare.com\/sk\/worldcare-consortium-mso-providers-dana-farber-and-boston-childrens-hospital-develop-a-preventive-measure-to-breast-cancer\/","title":{"rendered":"Poskytovatelia MSO od WorldCare Consortium\u00ae, Dana-Farber a Detsk\u00e1 nemocnica v Bostone, vyv\u00edjaj\u00fa prevent\u00edvne opatrenie proti rakovine prsn\u00edka."},"content":{"rendered":"<p>V\u00fdskumn\u00edci aj lek\u00e1ri si uvedomuj\u00fa d\u00f4le\u017eitos\u0165 prevencie alebo zvr\u00e1tenia priebehu rakoviny sk\u00f4r, ako sa pacienti dostan\u00fa do situ\u00e1cie, ke\u010f musia lie\u010di\u0165 pokro\u010dilej\u0161ie pr\u00edpady. Michael Goldberg, PhD., z Dana-Farberovej kliniky, prispel k spolo\u010dn\u00e9mu v\u00fdskumu, ktor\u00fd demon\u0161truje, ako by sa dali konkr\u00e9tnym pr\u00edpadom rakoviny predch\u00e1dza\u0165 alebo lie\u010di\u0165 sk\u00f4r, ako sa stan\u00fa mal\u00edgnymi.&nbsp;&nbsp;<\/p>\n\n\n\n<p>Goldberg v spolupr\u00e1ci s&nbsp;<a href=\"https:\/\/wyss.harvard.edu\/job\/bio-inspired-engineering\/\" target=\"_blank\" rel=\"noreferrer noopener\">Wyssov in\u0161tit\u00fat biologicky in\u0161pirovan\u00e9ho in\u017einierstva<\/a>&nbsp;na Harvardskej univerzite pou\u017eili strat\u00e9giu g\u00e9nov\u00e9ho knockdownu na \u010diasto\u010dn\u00e9 zvr\u00e1tenie skor\u00fdch pr\u00edpadov dukt\u00e1lneho karcin\u00f3mu in situ (DCIS) s pou\u017eit\u00edm laborat\u00f3rnych my\u0161\u00ed n\u00e1chyln\u00fdch na toto ochorenie. Zistenia z tejto \u0161t\u00fadie boli publikovan\u00e9 v ...&nbsp;<a href=\"http:\/\/stm.sciencemag.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">Veda o transla\u010dnej medic\u00edne.<\/a>&nbsp;Na z\u00e1klade t\u00fdchto v\u00fdsledkov Wyssov in\u0161tit\u00fat povzbudil Goldberga, aby navrhol syst\u00e9m, ktor\u00fd by mohol \u00faspe\u0161ne pren\u00e1\u0161a\u0165 fragmenty g\u00e9nov uml\u010duj\u00face naz\u00fdvan\u00e9 siRNA do buniek prsn\u00edka. Strat\u00e9giou, ktor\u00e1 sa za t\u00fdm skr\u00fdvala, bolo vypn\u00fa\u0165 g\u00e9n, ktor\u00fd v\u00fdskumn\u00edci predt\u00fdm ozna\u010dili za hlavn\u00fd g\u00e9n v raste DCIS. Tento n\u00e1stroj na doru\u010denie je zn\u00e1my ako RNA interferencia (RNAi), \u010do je prirodzen\u00fd biologick\u00fd syst\u00e9m na zn\u00ed\u017eenie g\u00e9novej aktivity.<\/p>\n\n\n\n<p>Dukt\u00e1lny karcin\u00f3m in situ je neinvaz\u00edvny karcin\u00f3m v mlie\u010dnych v\u00fdvodoch, ktor\u00fd neohrozuje \u017eivot, pokia\u013e bunky neunikn\u00fa z v\u00fdvodov a nevst\u00fapia do prsn\u00edka a in\u00fdch tkan\u00edv a nenapadn\u00fa ich. Tento neinvaz\u00edvny karcin\u00f3m bol pre v\u00fdskum k\u013e\u00fa\u010dov\u00fd, preto\u017ee 25 percent v\u0161etk\u00fdch diagn\u00f3z rakoviny prsn\u00edka je DCIS a z t\u00fdchto pacientok sa polovica stane invaz\u00edvnou. Mnoh\u00e9 pacientky sa rozhodn\u00fa pre lumpekt\u00f3miu alebo mastekt\u00f3miu a m\u00f4\u017eu podst\u00fapi\u0165 o\u017earovanie, aby sa zabr\u00e1nilo invaz\u00edvnemu n\u00e1rastu rakoviny.&nbsp;<a href=\"https:\/\/wyss.harvard.edu\/team\/executive-team\/donald-ingber\/\" target=\"_blank\" rel=\"noreferrer noopener\">Donald Ingber, MD, PhD.<\/a>, zakladaj\u00faci riadite\u013e spolo\u010dnosti Wyss a patol\u00f3g v Detskej nemocnici v Bostone, h\u013eadal alternat\u00edvu, ktor\u00e1 by zabr\u00e1nila tak\u00e9muto z\u00e1va\u017en\u00e9mu prevent\u00edvnemu opatreniu.<\/p>\n\n\n\n<p>Ingberov\u00e1 strategicky navrhla mo\u017enos\u0165 preh\u013ead\u00e1vania siete g\u00e9nov s cie\u013eom identifikova\u0165 k\u013e\u00fa\u010dov\u00e9 faktory rakoviny prsn\u00edka, h\u013eada\u0165 abnorm\u00e1lne g\u00e9ny, ktor\u00e9 naria\u010fuj\u00fa in\u00fdm g\u00e9nom, aby sa spr\u00e1vali nespr\u00e1vne, a potom ich blokova\u0165 cielen\u00fdmi molekul\u00e1rnymi \u010dinidlami.&nbsp;<a href=\"https:\/\/wyss.harvard.edu\/team\/core-faculty\/james-collins\/\" target=\"_blank\" rel=\"noreferrer noopener\">Jim Collins, PhD.<\/a>, \u010dlenka fakulty Wyss a profesorka na Bostonskej univerzite, a Hu Li, postdoktorandka v Collinsovom t\u00edme, pomocou po\u010d\u00edta\u010dov preh\u013ead\u00e1vali siete g\u00e9nov a h\u013eadali g\u00e9n, ktor\u00fd sa podozrivo spr\u00e1va tesne predt\u00fdm, ako za\u010dn\u00fa r\u00e1s\u0165 bunky mlie\u010dnych v\u00fdvodov v prsn\u00edku. V\u00fdsledkom bola identifik\u00e1cia hlavn\u00e9ho podozriv\u00e9ho, g\u00e9nu zn\u00e1meho ako HoxA1, ktor\u00fd m\u00e1 \u0161tatistick\u00fa s\u00favislos\u0165 s rakovinou prsn\u00edka, ktor\u00e1 predt\u00fdm s t\u00fdmto ochoren\u00edm nebola spojen\u00e1. Postdoktorandka Amy Brock, Ph.D., z Ingberovho t\u00edmu, pou\u017eila siRNA na lie\u010dbu buniek my\u0161\u00ed aj \u013eud\u00ed a zistila, \u017ee tlmia g\u00e9n HoxA1 a sp\u00f4sobuj\u00fa, \u017ee sa bunky vr\u00e1tia do malignity. SiRNA v\u0161ak nem\u00f4\u017ee prejs\u0165 cez bunkov\u00fa membr\u00e1nu, a tak sa obr\u00e1tili sp\u00e4\u0165 na Goldberga, ktor\u00fd syntetizoval molekuly naz\u00fdvan\u00e9 lipidoidy, ktor\u00e9 by sa mohli pou\u017ei\u0165 ako mechanizmus dod\u00e1vania siRNA.<\/p>\n\n\n\n<p>Goldbergov pr\u00edstup, ozna\u010dovan\u00fd ako&nbsp;<em>Tr\u00f3jsky k\u00f4\u0148<\/em>&nbsp;Tento pr\u00edstup sp\u00f4sobil, \u017ee g\u00e9ny boli v tele uml\u010dan\u00e9 na cel\u00e9 t\u00fd\u017edne. Ke\u010f\u017ee mechanizmus pod\u00e1vania g\u00e9nov fungoval, Goldberg nechal v\u00fdskumn\u00edkov vstrekn\u00fa\u0165 tieto nano\u010dastice s obsahom siRNA priamo do mliekovodu cez bradavku infikovan\u00fdch my\u0161\u00ed. V\u00fdsledkom bolo, \u017ee infikovan\u00e9 my\u0161i zostali zdrav\u00e9, zatia\u013e \u010do u nelie\u010den\u00fdch my\u0161\u00ed sa vyvinula rakovina prsn\u00edka. Goldberg uviedol: \u201cV\u010faka obrovskej multidisciplin\u00e1rnej spolupr\u00e1ci n\u00e1\u0161 t\u00edm \u00faspe\u0161ne zabr\u00e1nil vzniku rakoviny prsn\u00edka u my\u0161\u00ed, ktor\u00e9 boli geneticky predisponovan\u00e9 k vzniku tohto ochorenia. Hoci je implement\u00e1cia tohto konceptu v klinick\u00fdch \u0161t\u00fadi\u00e1ch e\u0161te roky vzdialen\u00e1, ukazuje ve\u013ek\u00fd potenci\u00e1l pod\u00e1va\u0165 siRNA \u017een\u00e1m so zv\u00fd\u0161en\u00fdm rizikom rakoviny prsn\u00edka, aby sa zabr\u00e1nilo jej vzniku.\u201d<\/p>\n\n\n\n<p>Ak ste \u010dlenkou WorldCare a bola v\u00e1m diagnostikovan\u00e1 rakovina prsn\u00edka,&nbsp;<a href=\"https:\/\/www.worldcare.com\/sk\/kontakt\/\">po\u017eiada\u0165 o druh\u00fd n\u00e1zor<\/a>&nbsp;dnes.<\/p>","protected":false},"excerpt":{"rendered":"<p>Researchers and doctors alike recognize the importance of preventing or reversing cancer before patients are in the position of having to treat more advanced cases. Michael Goldberg, Ph.D., of Dana-Farber has contributed to a collaborative group effort into research that demonstrates how particular cancer cases could be prevented and or treated before becoming malignant.&nbsp;&nbsp; Goldberg [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2973,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[71,46,73,70,72],"class_list":["post-2972","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","tag-breast-cancer","tag-cancer","tag-childrens-hospital","tag-medical-treatment","tag-prevention"],"_links":{"self":[{"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/posts\/2972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/comments?post=2972"}],"version-history":[{"count":0,"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/posts\/2972\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/media\/2973"}],"wp:attachment":[{"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/media?parent=2972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/categories?post=2972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.worldcare.com\/sk\/wp-json\/wp\/v2\/tags?post=2972"}],"curies":[{"name":"pracovn\u00fd list","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}